Hints and tips:
Related Special Reports
...The new platform would pull together these disparate offerings, the people said....
...of a majority stake to a consortium of investors led by New Mountain Capital....
...Cathie Wood’s Ark Investment Management is launching its first three active exchange traded funds in Europe, courting a new continent of investors after a run of poor performance and outflows in the US....
...The division had roots in Credit Suisse First Boston’s New York mortgage securitisation business in the 1980s and was led by veteran executive Jay Kim, who moved with most of the team to Atlas SP when the...
...The sale of a majority stake to New Mountain represents the biggest private equity deal in the sector....
...and then distribute it under its own brand.Under the agreement, California will buy naloxone, a nasal spray that can reduce or reverse the effects of opioids, from generics manufacturer Amneal Pharmaceuticals...
...The drugmaker has also now broken ground on a new site in Germany....
...The New York Stock Exchange is polling market participants on the merits of trading stocks around the clock as regulators scrutinise an application for the first 24/7 bourse....
...“By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs, forcing Americans to pay sky-high prices for medicines they rely on,” said FTC chair Lina...
...New York-based group Apollo on Thursday increased its long-term forecasts for its lending business, telling shareholders it expected to be able to originate more than $200bn a year in new loans, up from...
...of the takeover effort, the people familiar with it said....
...In January 2023, New York-based Quintessential Capital Management published a report alleging Darktrace appeared to have simulated or anticipated sales to “phantom” customers through a “network of willing...
...The managers at New York-based OrbiMed — the biggest team of healthcare specialists in the world, says Angell — hold “a nice mix” of defensive healthcare stocks with a leavening of emerging biotech businesses...
...But it is a new generation of non-addictive painkillers that analysts say are the most promising drugs in Vertex’s pipeline....
...Nicholas Emiliou, advocate general of the Court of Justice of the EU, said on Thursday that EU judges should set aside an earlier judgment that sided with the commission....
...The decision to convene the panel shows the high degree of caution with which the FDA is approaching a new class of drugs that have historically come with harsh criminal penalties in combination with therapy...
...The tech giant is also running a 10-year partnership with Deutsche Börse, while New York’s Nasdaq is working with Amazon Web Services....
...Pfizer: The pharmaceutical company is expected to report that quarterly revenue declined 23.4 per cent from the same period last year to $14bn, according to LSEG, as the company faces weak demand for its...
...J&J shares closed 4.6 per cent higher on Wednesday in New York....
...Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage clinical trial, the pharmaceutical group said on Wednesday, adding to evidence that could encourage more...
...Earnings per share stood at $2.58 in the first quarter, ahead of analysts’ expectations of $2.48. Read more here...
...“But a large number of German inspectors are afraid to travel to China because of the new national security law”....
...The New York-based firm raised a $12.7bn fund in 2021 and has built stakes in TikTok parent company ByteDance, fast-fashion company Shein and payments company Stripe....
...Rahul Titus, global head of influence at Ogilvy PR, said health influence was the “new frontier” in marketing....
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
International Edition